Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Classification
Class III
Status
Completed
Lot
Lot # AD12890, Exp 09/30/2024
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Taro Pharmaceuticals U.S.A., Inc. — Class III Recall | MedicineWatch US